Cardlytics (NASDAQ:CDLX) CFO Acquires $97,500.00 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) CFO David Thomas Evans acquired 150,000 shares of the firm’s stock in a transaction on Friday, May 15th. The stock was purchased at an average cost of $0.65 per share, with a total value of $97,500.00. Following the completion of the transaction, the chief financial officer owned 267,930 shares in the company, valued at $174,154.50. The trade was a 127.19% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this link.

David Thomas Evans also recently made the following trade(s):

• On Monday, May 18th, David Thomas Evans purchased 50,000 shares of Cardlytics stock. The shares were bought at an average cost of $0.63 per share, for a total transaction of $31,500.00.

Cardlytics Stock Performance

Shares of CDLX stock traded down $0.01 during trading hours on Tuesday, hitting $0.60. 865,741 shares of the company were exchanged, compared to its average volume of 1,103,752. Cardlytics, Inc. has a one year low of $0.57 and a one year high of $3.28. The business’s 50-day simple moving average is $0.87 and its two-hundred day simple moving average is $1.06. The stock has a market capitalization of $34.34 million, a price-to-earnings ratio of -0.34 and a beta of 0.67.

Cardlytics (NASDAQ:CDLX) last issued its quarterly earnings results on Wednesday, March 4th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.08). Cardlytics had a negative return on equity of 956.56% and a negative net margin of 46.03%.The company had revenue of $56.10 million for the quarter, compared to the consensus estimate of $54.46 million. As a group, analysts anticipate that Cardlytics, Inc. will post -0.11 EPS for the current fiscal year.

Institutional Investors Weigh In On Cardlytics

Several large investors have recently made changes to their positions in CDLX. Vanguard Personalized Indexing Management LLC acquired a new stake in shares of Cardlytics in the third quarter valued at approximately $26,000. Virtu Financial LLC acquired a new stake in shares of Cardlytics in the fourth quarter valued at approximately $39,000. Qube Research & Technologies Ltd acquired a new position in shares of Cardlytics during the third quarter valued at approximately $55,000. Marshall Wace LLP acquired a new position in shares of Cardlytics during the second quarter valued at approximately $59,000. Finally, Renaissance Technologies LLC acquired a new position in shares of Cardlytics during the fourth quarter valued at approximately $62,000. Institutional investors and hedge funds own 68.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on CDLX. Lake Street Capital set a $1.00 target price on shares of Cardlytics in a report on Friday, May 8th. Weiss Ratings restated a “sell (e+)” rating on shares of Cardlytics in a research note on Friday, April 10th. Evercore set a $1.00 price target on shares of Cardlytics in a research note on Friday, March 6th. Bank of America restated an “underperform” rating on shares of Cardlytics in a research note on Thursday, March 5th. Finally, Wall Street Zen upgraded shares of Cardlytics from a “sell” rating to a “hold” rating in a research note on Saturday, April 4th. One analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Sell” and a consensus target price of $1.00.

Cardlytics Company Profile

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.